(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus - PubMed (original) (raw)
. 2013 Aug;380(1-2):211-8.
doi: 10.1007/s11010-013-1675-x. Epub 2013 May 10.
Affiliations
- PMID: 23660953
- DOI: 10.1007/s11010-013-1675-x
(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus
Ning Jia et al. Mol Cell Biochem. 2013 Aug.
Abstract
Alzheimer's disease (AD) fundamentally represents a metabolic disease associated with brain insulin resistance. TNF-α/c-Jun N-terminal kinase (JNK) signaling plays a central role in serine phosphorylation of insulin receptor substrate-1 (IRS-1). (-)-Epigallocatechin-3-gallate (EGCG), a potent antioxidant, has been verified to attenuate peripheral insulin resistance by reducing IRS-1 signaling blockage. This study aimed to investigate the effects and possible mechanisms of EGCG on central IRS-1 signaling in vivo. APP/PS1 mice were treated with EGCG, and spatial memory was assessed by the Morris water maze test. Levels of soluble and insoluble Aβ42 in the hippocampus were determined by ELISA. The activation of NF-α/JNK and IRS signaling was detected by immunohistochemistry and Western blot analysis. Our results showed that EGCG ameliorated the impaired learning and memory in APP/PS1 mice. Notably, we found a significant reduction of IRS-1pS636 level accompanied with decreased Aβ42 levels in the hippocampus of 13-month-old female APP/PS1 mice after treatment with EGCG (2 or 6 mg/kg/day) for 4 weeks. Furthermore, EGCG treatment inhibited TNF-α/JNK signaling and increased the phosphorylation of Akt and glycogen synthase kinase-3β in the hippocampus of APP/PS1 mice. In conclusion, our study provides evidence that long-term consumption of EGCG may alleviate AD-related cognitive deficits by effectively attenuating central insulin resistance.
Similar articles
- Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Ettcheto M, Cano A, Manzine PR, Busquets O, Verdaguer E, Castro-Torres RD, García ML, Beas-Zarate C, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Mol Neurobiol. 2020 Apr;57(4):1814-1827. doi: 10.1007/s12035-019-01849-6. Epub 2019 Dec 14. Mol Neurobiol. 2020. PMID: 31838720 - CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K, Jin J, Zhu X, Yu L, Wang S, Qian L, Han L, Xu Y. Yin K, et al. Neurol Res. 2017 Oct;39(10):885-894. doi: 10.1080/01616412.2017.1348689. Epub 2017 Jul 25. Neurol Res. 2017. PMID: 28743230 - Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautschy SA, Cole GM. Ma QL, et al. J Neurosci. 2009 Jul 15;29(28):9078-89. doi: 10.1523/JNEUROSCI.1071-09.2009. J Neurosci. 2009. PMID: 19605645 Free PMC article. - Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases.
Zhao Y, Kuca K, Wu W, Wang X, Nepovimova E, Musilek K, Wu Q. Zhao Y, et al. Alzheimers Dement. 2022 Jan;18(1):152-158. doi: 10.1002/alz.12370. Epub 2021 May 25. Alzheimers Dement. 2022. PMID: 34032377 Review. - Epigallocatechin Gallate: A Multifaceted Molecule for Neurological Disorders and Neurotropic Viral Infections.
Rani A, Saini V, Patra P, Prashar T, Pandey RK, Mishra A, Jha HC. Rani A, et al. ACS Chem Neurosci. 2023 Sep 6;14(17):2968-2980. doi: 10.1021/acschemneuro.3c00368. Epub 2023 Aug 17. ACS Chem Neurosci. 2023. PMID: 37590965 Review.
Cited by
- JNK/PI3K/Akt signaling pathway is involved in myocardial ischemia/reperfusion injury in diabetic rats: effects of salvianolic acid A intervention.
Chen Q, Xu T, Li D, Pan D, Wu P, Luo Y, Ma Y, Liu Y. Chen Q, et al. Am J Transl Res. 2016 Jun 15;8(6):2534-48. eCollection 2016. Am J Transl Res. 2016. PMID: 27398138 Free PMC article. - Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
Ettcheto M, Cano A, Manzine PR, Busquets O, Verdaguer E, Castro-Torres RD, García ML, Beas-Zarate C, Olloquequi J, Auladell C, Folch J, Camins A. Ettcheto M, et al. Mol Neurobiol. 2020 Apr;57(4):1814-1827. doi: 10.1007/s12035-019-01849-6. Epub 2019 Dec 14. Mol Neurobiol. 2020. PMID: 31838720 - Effects of Daily Matcha and Caffeine Intake on Mild Acute Psychological Stress-Related Cognitive Function in Middle-Aged and Older Adults: A Randomized Placebo-Controlled Study.
Baba Y, Inagaki S, Nakagawa S, Kobayashi M, Kaneko T, Takihara T. Baba Y, et al. Nutrients. 2021 May 17;13(5):1700. doi: 10.3390/nu13051700. Nutrients. 2021. PMID: 34067795 Free PMC article. Clinical Trial. - The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
Sabogal-Guáqueta AM, Muñoz-Manco JI, Ramírez-Pineda JR, Lamprea-Rodriguez M, Osorio E, Cardona-Gómez GP. Sabogal-Guáqueta AM, et al. Neuropharmacology. 2015 Jun;93:134-45. doi: 10.1016/j.neuropharm.2015.01.027. Epub 2015 Feb 7. Neuropharmacology. 2015. PMID: 25666032 Free PMC article.
References
- Neuron. 2008 Jun 12;58(5):708-19 - PubMed
- Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12 - PubMed
- J Agric Food Chem. 2012 Feb 1;60(4):1059-66 - PubMed
- Trends Endocrinol Metab. 2012 Mar;23(3):133-41 - PubMed
- Biochimie. 2005 Jan;87(1):99-109 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous